These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26777410)

  • 1. Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease.
    Flamez A; Cordenier A; De Raedt S; Michiels V; Smetcoren S; Van Merhaegen-Wieleman A; Parys E; De Keyser J; Baeken C
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26777410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease.
    Sayın S; Cakmur R; Yener GG; Yaka E; Uğurel B; Uzunel F
    J Clin Neurosci; 2014 Aug; 21(8):1373-6. PubMed ID: 24631324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
    Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease.
    Brusa L; Versace V; Koch G; Iani C; Stanzione P; Bernardi G; Centonze D
    Clin Neurophysiol; 2006 Sep; 117(9):1917-21. PubMed ID: 16887383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets.
    Koch G
    Restor Neurol Neurosci; 2010; 28(4):561-8. PubMed ID: 20714078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of one session of 1 Hz rTMS on functional connectivity between pre-supplementary motor area and putamen depending on the dyskinesia state in Parkinson's disease.
    Flamez A; Wu GR; Wiels W; Van Schuerbeek P; De Mey J; De Keyser J; Baeken C
    Clin Neurophysiol; 2021 Apr; 132(4):851-856. PubMed ID: 33636601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
    Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
    Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar and Motor Cortical Transcranial Stimulation Decrease Levodopa-Induced Dyskinesias in Parkinson's Disease.
    Ferrucci R; Cortese F; Bianchi M; Pittera D; Turrone R; Bocci T; Borroni B; Vergari M; Cogiamanian F; Ardolino G; Di Fonzo A; Padovani A; Priori A
    Cerebellum; 2016 Feb; 15(1):43-47. PubMed ID: 26542731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease.
    Koch G; Brusa L; Caltagirone C; Peppe A; Oliveri M; Stanzione P; Centonze D
    Neurology; 2005 Aug; 65(4):623-5. PubMed ID: 16116131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
    Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
    Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
    Kishore A; Popa T; Balachandran A; Chandran S; Pradeep S; Backer F; Krishnan S; Meunier S
    Cereb Cortex; 2014 Aug; 24(8):2055-67. PubMed ID: 23535177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal bidirectional plasticity-like effects in Parkinson's disease.
    Huang YZ; Rothwell JC; Lu CS; Chuang WL; Chen RS
    Brain; 2011 Aug; 134(Pt 8):2312-20. PubMed ID: 21742734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.
    Koch G; Brusa L; Carrillo F; Lo Gerfo E; Torriero S; Oliveri M; Mir P; Caltagirone C; Stanzione P
    Neurology; 2009 Jul; 73(2):113-9. PubMed ID: 19597133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of one session of low frequency rTMS on pre-supplementary motor area metabolites in late stage Parkinson's disease.
    Flamez A; Wiels W; Van Schuerbeek P; De Mey J; De Keyser J; Baeken C
    Clin Neurophysiol; 2019 Aug; 130(8):1292-1298. PubMed ID: 31176928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
    Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
    Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease.
    Kodama M; Kasahara T; Hyodo M; Aono K; Sugaya M; Koyama Y; Hanayama K; Masakado Y
    Am J Phys Med Rehabil; 2011 Feb; 90(2):150-5. PubMed ID: 20975525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels.
    Sanna A; Follesa P; Puligheddu M; Cannas A; Serra M; Pisu MG; Dagostino S; Solla P; Tacconi P; Marrosu F
    Neurosci Lett; 2020 Jan; 716():134653. PubMed ID: 31778767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical response to levodopa in Parkinson's disease patients with dyskinesias.
    Turco F; Canessa A; Olivieri C; Pozzi NG; Palmisano C; Arnulfo G; Marotta G; Volkmann J; Pezzoli G; Isaias IU
    Eur J Neurosci; 2018 Sep; 48(6):2362-2373. PubMed ID: 30117212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.